Belén Garijo: A very important evolution of Merck Group’s Executive Board
Belén Garijo, Chair of the Executive Board and CEO of Merck, shared on LinkedIn:
“Today, we have announced a very important evolution of our Executive Board at Merck Group.
After putting Life Science and Healthcare on a path to sustainable growth, both Matthias Heinzel and Peter Guenter are now passing on the baton to Jean-Charles Wirth and Danny Bar-Zohar.
I want to extend my most sincere gratitude to Matthias and Peter for their strong leadership of their business sectors during very challenging times these past years. I have personally enjoyed working with them as a team.
Additionally, we have announced the creation of a new Executive Board position, Chief People Officer, to showcase how important people, talent and culture are to Merck’s long-term success. And I am delighted about the appointment of Khadija Ben Hammada to that role.
My warmest congratulations to Jean-Charles, Danny and Khadija. Their appointment is a testament to the strength of our internal talent bench and our commitment to developing leaders from within.
The collective focus of the new Executive Board team remains firmly on Growth, Innovation, and People. We will continue building on our strong foundation while shaping the future of our company together with more than 62,000 colleagues worldwide, who are the driving force behind our success.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023